RESEARCH ALERT-UBS cuts Endo Pharmaceuticals price target

Oct 5 (Reuters) - Endo Health Solutions Inc :

* UBS cuts Endo Pharmaceuticals price target to $45 from $50; rating

buy

For a summary of rating and price target changes on U.S. companies:

Reuters Eikon users, click on

Reuters 3000Xtra users, double-click

Reuters Station users, click .1568

For a summary of rating and price target changes on Canadian companies:

Reuters Eikon users, click on

Reuters 3000Xtra users, double-click

Reuters Station users, click .4899

((Bangalore Newsroom [phone]; within U.S. [phone]))